Arca
Skip to content

ESR2: Estrogen receptor beta

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Nuclear hormone receptor.

  • Drugs that act on it: 8
  • With a US drug page: 3
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
ChlorotrianiseneApprovedEstrogen receptor beta modulatorModulator—
Estramustine phosphateApprovedEstrogen receptor beta modulatorModulator—
RaloxifeneApprovedEstrogen receptor beta modulatorModulatorBoxed warning
AUS-131—Estrogen receptor beta agonistAgonist—
CR 1447—Estrogen receptor beta agonistAgonist—
Erteberel—Estrogen receptor beta agonistAgonist—
MF101—Estrogen receptor beta agonistAgonist—
Prinaberel—Estrogen receptor beta agonistAgonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Postmenopausal osteoporosis
0.58
Menopause
0.57
Dyspareunia
0.56
Atrophy
0.55
Neoplasm
0.49
Breast carcinoma
0.49
Hypogonadism
0.47
Primary ovarian failure
0.47
Atrophic Vaginitis
0.47

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
ESR2

Drugs and mechanisms are from ChEMBL CHEMBL242 (CC BY-SA 3.0). Gene name, function (UniProt Q92731, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.